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Preface and Acknowledgements 
 When choosing a topic for my thesis, I wanted to find a subject that combined my 
current educational journey with my future one. In other words, I wanted to find a topic 
where neuroscience and physical therapy merged. While the topic of phantom limb pain 
has come up in some of my neuroscience classes, I really began to fall in love the with 
the complexity of it while reading Phantoms in the Brain by Ramachandran and 
Blakeslee (a quotation from this book can be found in Chapter 2 of my thesis). 
Ramachandran not only hypothesized his own theory behind phantom limb pain, but 
developed a physical therapy practice known as mirror therapy to help treat the disorder. 
This made phantom limb pain a perfect fit, as it allowed me to use my background in 
neuroscience to explore the mechanisms of the disorder, as well as investigate how we 
treat the disorder.   
 First, I would like to thank Dr. Ashley Fricks-Gleason, my advisor, for her 
support through the duration of the process. She was always there to encourage me, keep 
me on track, and help me improve my writing. Dr. Fricks-Gleason has continually 
expanded my love for neuroscience throughout my time at Regis University. Secondly, I 
would like Dr. Amanda Hine, my reader, for her aid in this project. I went into this 
process knowing very little about bioethics. Dr. Hine helped me develop my arguments 
as well as demonstrated to me the importance of the field.  
 I would also like to thank the Regis University Honors Department for the 
opportunity to embark on such an incredible scholastic endeavor. The support and 
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advising of Dr. Thomas Howe, Dr. Catherine Kleier, and Dr. Lara Narcisi helped me 
chose a topic that I fell in love with over the course of the last year and a half. I would 
also like to thank the rest of my honors cohort for four years of profound discussion.  
 Finally, I would like to thank my family and friends for supporting me throughout 
this journey. They were there to back me through all the ups and downs of this process. 
Particularly, I would like to thank my parents, without their encouragement I would not 
be the scholar or person I am today.   
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CHAPTER 1: PHANTOM LIMB PAIN 
History 
In 1536, a man named Ambroise Paré joined the French army as a surgeon.  He 
became a leading pioneer of surgery, specifically amputation (Axoiti, Geramani, Sarbu, 
& Karamanou, 2014). During the mid-sixteenth century, deep gunshot wounds would 
lead to gangrene. Because of this, amputation was necessary. At the time, cauterizing the 
wound was the most widespread way to stop the bleeding, but Paré looked for more 
effective, less painful methods. Paré began to use ligatures, silk thread, to tie around the 
blood vessels to stop the bleeding. However, at the time, this process was too slow and 
ineffective due to the lack of antiseptics. During his time as a military surgeon, it is 
believed that Paré was the first to report and write about amputee soldiers that were still 
cognizant of their missing limb (Richardson, 2010). The first time that Paré describes the 
syndrome is in The Method of Treating Wounds Made by Harquebuses and Other Guns), 
Paré portrays the syndrome as well as provides multiple different models for such pain 
(L. Nikolajsen & Jensen, 2001). In Chapter 23 of his complete works, Paré writes, “The 
patients imagine they have their members yet entire, and yet doe complain thereof (which 
I imagine come to pass, for that, the cut nerves retire themselves towards their original, 
and thereby cause a pain like to convulsions)” (Paré, 1575, as cited in Finger & Hustwit, 
2003, p. 677)  In other words, Paré describes that the individual has a painful sensation as 
though their whole limb is still intact. He then continues that he believes the cut nerve is 
the reason for this pain. In this quote, it can be seen that Paré hypothesizes that the 
painful sensation (phantom limb) comes from the nerve being cut during amputation.  
 2 
 
After Paré, others began to describe this pain in missing limbs. In 1830, Charles 
Bell published a monograph called The Nervous System of the Human Body. This 
monograph serves as the first descriptor of several different neurological disorders. In it, 
Bell describes an amputee who still has phantom limb pain and the perception of motion. 
Bell theorizes that the reason for this phantom limb is “muscular sense,” a term that he 
had already coined (Furukawa, 1990). In this, Bell describes how individuals know where 
their muscles are without the need for touch, and this is the reason that phantom limb 
pain exists. Bell’s understanding of muscular sense is similar to our current view of 
proprioception. Currently, proprioception has a similar definition in that proprioception is 
the ability to understand the location of our body parts in regards to other parts, including 
body equilibrium and balance. Magendie (1833), Rhone (1842), and Gueniot (1862) also 
provided detailed descriptions of phantom limb (L. Nikolajsen & Jensen, 2001).  
In 1866, a Civil War surgeon named Silas Weir Mitchell published a piece in The 
Atlantic Monthly. The article called “The Case of George Dedlow” describes a surgeon 
whose training is interrupted by entering the Union Army as an infantry officer (Mitchell, 
1866). During his time in the army, George Dedlow loses all four of his limbs to 
amputation.  The story goes on to discuss a head and trunk who still feel sensations of the 
missing limbs. The work of Mitchell is of particular interest to scientists because of its 
accurate depiction of the neurological issues such as these phantom sensations (Canale, 
2004). This story made a large impact on the general public because of this depiction as 
well as the ending in which it describes a séance in which Dedlow is reunited with his 
legs. At the beginning of the article, Mitchell (2004) says “I ought to add, that a good 
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deal of what is here related is not of any scientific value whatsoever,” (p. 113). Even with 
this statement, the article had a large impact on the public perception of amputation.  
It is Silas Weir Mitchell who was the first to attribute the term “phantom” to these 
sensations that he describes in the “The Case of George Dedlow” (Richardson, 2010).  
Furthermore, Mitchell coined the term phantom limb pain, what these sensations are 
called now. In 1872, Mitchell discusses the phenomenon in a scientific manner in his 
book Injuries of the Nerves and their Consequences. In the chapter “Neural Maladies of 
Stumps,” Mitchell gives case examples of the physiology of the stump and the sensory 
hallucinations that come with it (Mitchell, 1872). In his book he states, “Among ninety 
cases, including a great variety of amputations, I have found but four cases—two of an 
arm, the others of legs—in which there never had been delusion as to the presence of the 
absent member,” (Mitchell, 1970, p. 348). He goes on to discuss the faradization of the 
stump of an arm, which produces a feeling in the hand. Faradization is the stimulation of 
the stump of the arm with electrical current. In his account, Mitchell is describing what 
we have come to know as phantom sensations. Mitchell describes the sensory 
impressions behind such a feeling, and as such, defines his own version of why he 
believes phantom limb sensation exists.  
Reports on this pain continued into modern times due to amputations in World 
War I, World War II, the Vietnam War, and the Israeli war (Edwards, Mayhew, & Rice, 
2014; Foote, Kinnon, Robbins, Pessagno, & Portner, 2015; Heszlein-Lossius et al., 2018; 
Machin & Williams, 1998). Continued research investigated other reasons for amputation 
such as peripheral vascular disease (commonly due to arteriosclerosis and neoplasms 
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(benign or malignant growths; L. Nikolajsen & Jensen, 2001). During this time, it was 
believed that phantom limb pain existed in a small subset of individuals and early 
research showed the incidence of such pain to be around 4% (Henderson & Smyth, 
1948). At this time, phantom limb pain was measured by whether a patient asked for pain 
medication or not, and this is most likely the reason why newer research has found a 
higher percentage for the incidences of pain (L. Nikolajsen & Jensen, 2001).  
From Paré’s time in 1536, a number of hypotheses and theories have been 
developed in order to explain this phantom limb pain (Finger & Hustwit, 2003). Bell used 
“muscular sense” to explain the pain, while Mitchell, describes it as being due to sensory 
impressions. Even with the identification of the disorder such a long time ago, the 
neurological phenomenon of phantom limb pain and the mechanisms behind it are still 
not fully understood (Flor, Nikolajsen, & Jensen, 2006). 
Phantom Limb Prevalence and Variances  
Before beginning a discussion behind the etiology of phantom limb pain, it is 
important to differentiate it from phantom sensations and residual limb pain (or stump 
pain). Phantom limb sensation is any sensation felt in the amputated limb that is not pain. 
Residual limb pain is any pain felt in the stump of the amputated limb (Ahmed et al., 
2017). Phantom limb pain is a painful sensation in reference to the missing limb. This 
pain can begin as early as right after the removal of the limb, and can be described as any 
combination of the following descriptors: “stinging, cutting, piercing, radiating, tight, 
nagging, squeezing, tingling, and shocking” (Ehde et al., 2000, p. 1040). While phantom 
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limb pain is normally thought of as pain to an amputated limb, this pain can be found 
from removing other parts of the body. Examples include, but are not limited to pain in 
removed teeth, genital organs, bladder and breasts (Woodhouse, 2005). Even though it is 
not uncommon for phantom limb pain to occur in these areas, most research on phantom 
limb pain is focused on amputated limbs.  
There is a large amount of variation within phantom limb pain among individuals 
with amputations. Such variation can be found in the intensity and duration of the pain. 
For most individuals, the phantom limb pain is episodic and is not constant (Whyte & 
Niven, 2001). On a scale of 0 (no pain) to 10 (pain as bad as it could be), an average pain 
score of 5.1 was found (Ehde et al., 2000).  It is important to note that the standard 
deviation was 2.6, showing that there is large individual variability in the intensity of the 
pain. Furthermore, in this same study, when looking at the duration of the pain, over half 
of the individuals reported their pain only lasting a few minutes (52%), while others 
reported periods of an hour (26%). While there is variation in the episodes of phantom 
limb pain, there seems to be no difference in reports of phantom limb pain in regards to if 
the limb is an upper or lower extremity (Poor Zamany Nejat Kermany, Modirian, 
Soroush, Masoumi, & Hosseini, 2008).  
There are also variations in when phantom limb pain first occurs, and how outside 
variables can impact the incidence of it. Jensen, Krebs, Nielsen, & Rasmussen (1983) 
found that 47 percent of individuals had pain in the first 24 hours following amputation. 
This number grew to 84 percent eight days post-operation, and 90 percent after six 
months (T. S. Jensen et al., 1983). A study by Ehde et al. (2000) reported a slightly 
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smaller number of 72 percent of individuals had phantom pain within six months of their 
amputation. That is to say that roughly half of the individuals first experience phantom 
limb pain within a day, but the onset can still occur up to six months following 
amputation.  Additionally, it has been shown that environmental factors can increase the 
incidence of pain. Environmental factors such as pre-amputation pain, smoking after 
proximal level of amputation, and postoperative analgesia have all be found to increase 
pain levels (Ahmed et al., 2017; Yin et al., 2017). On the other hand, presurgical 
interventions such as perioperative epidural blockade do not seem to prevent the onset of 
phantom limb pain (Nikolajsen, Ilkjaer, Christensen, Krøner, & Jensen, 1997). 
Theories Behind Phantom Limb Pain 
Just like the variance within the pain itself, there are variations in the theories 
describing phantom limb pain. The neurological mechanism of phantom limb pain is still 
unknown.  At first, theories revolving around phantom limb pain were psychological in 
nature, but now there is increasing evidence that the pain is neurological in nature (Flor et 
al., 2006; Raffin, Richard, Giraux, & Reilly, 2016; Seo et al., 2017). Three main theories 
have been implicated in phantom limb pain and involve the peripheral nervous system, 
the central nervous system, and body schema.   
Peripheral nervous system. 
The peripheral nervous system includes all parts of the nervous system except for 
the brain and spinal cord. A study done by Zeng, Wang, Guo, He, & Ni (2016) showed 
similar results when performing neuroma infiltrations, only the pain in the stump was 
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reduced. They had different results when performing a nerve block. In this study, a 
femoral and sciatic nerve block was performed and the result was longer pain relief. 
There was an 80% pain reduction in both stump pain and phantom limb pain that lasted 
40 hours for the subject (Zeng et al., 2016). This study was only a case report, and 
because of this, the effect of targeting of the femoral and sciatic nerves might be different 
with a larger subject pool, or the results may vary with an upper extremity.  
With this being said, intravenous regional anesthesia has been noted to give rise to 
phantom limb pain in individuals without amputation (Dominguez, 2001; Paqueron, 
Lauwick, Le Guen, & Coriat, 2004). Reports have been given where the body part feels 
like a phantom and is stuck in one position until intravenous regional anesthesia is 
stopped. It should be noted, that intravenous regional anesthesia does not normally have 
this effect on individuals. Still, these reports show that the peripheral nervous system 
might have a larger effect on phantom limb pain than previously thought.  
Other theories that pinpoint the peripheral nervous system as the reason behind 
the pain focus on spinal nerves. There are two roots leading into/out of the spinal cord, 
the dorsal root and the ventral root. The dorsal root is responsible for the afferent, or 
incoming, sensory information; whereas the ventral root is responsible for the efferent, or 
outgoing, motor information. In a study by Vaso et al. (2014), they suggest that phantom 
limb pain is caused by an increased input from afferent sensory inputs to the dorsal root 
ganglion. This increased sensory input is due to axotomized (cut axons of) neurons 
during amputation. In their study, an intraforaminal block almost completely reduced 
phantom limb pain in their subjects, suggesting that the dorsal root ganglion is the 
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spontaneous generator of a phantom limb. In this study, they only blocked one root, while 
multiple roots innervate the leg for sensory stimulation. The exact reason for why it still 
provided relief is unknown, but it could be because the majority of cases with phantom 
limb experience the pain in the foot, and this was the root that was blocked.  
Even with all of this evidence, most have abandoned peripheral nervous system 
theories due to the fact that phantom limb pain frequently persists despite neuroma 
infiltration and nerve/plexus block (Birbaumer et al., 1997). These types of treatment 
tend to alleviate stump pain, but not phantom limb pain. Therefore, a large proportion of 
phantom limb pain research has since been directed on the origin of phantom limb pain 
being in the central nervous system. 
In summary, while research has been steering away from the peripheral nervous 
system for answers with regard to phantom limb pain, it seems to still have some 
involvement. It is now known that the involvement is not directly at the site of the 
neuroma but may be higher up along the peripheral nervous system. This could mean 
increased activity at the spinal nerves themselves (as seen by the femoral and sciatic 
nerve blocks) or even as high up as the dorsal roots.  
Central nervous system. 
The central nervous system contains the brain and the spinal cord. Phantom limb 
pain theories that involve the central nervous system identify maladaptive brain plasticity 
as the cause (Birbaumer et al., 1997; Flor et al., 2006). There are multiple locations in 
which this brain plasticity begins to take place. They include the primary somatosensory 
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cortex (postcentral gyrus), the primary motor cortex (precentral gyrus), and within 
commissural fibers (connecting the two hemispheres of the brain).  
 Within the somatosensory strip, certain areas are devoted to certain body parts. 
This is often described as a homunculus (Snyder & Whitaker, 2013). This image depicts 
both the somatosensory and motor strips and shows what area of each strip is devoted to 
what body part. When a limb is amputated, this cortical organization begins to restructure 
(de Klerk, Johnson, & Southgate, 2015). When the trunk or face is stimulated on the 
ipsilateral side of the amputation, phantom limb sensations can be evoked  (Knecht et al., 
1996). The trunk and the face are the two regions that are next to the arm on the 
homunculus. Moreover, when assessed with MRI imaging, the cortical region for the 
limb is also evoked when the trunk or face is stimulated (Knecht et al., 1996).  This 
sensation is not limited to just the ipsilateral side though, as contralateral stimulation also 
causes some sensation and because of this, interhemispheric structures must also be 
involved. Additionally, artificial stimulation can be engineered in humans (Lee et al., 
2018). In a study by Lee et al. (2018), they stimulated the cortex with subdural mini-
electrocorticography grids. In doing so, they were able to induce artificial somatization 
during a behavioral task. By varying parameters such as increased pulse width, current 
strength, and frequency, they increased such sensations. With this being said, the cortical 
structure for the area is still relatively intact and resembles closely to that of a normal 
cortex (Björkman et al., 2012). In the study by Bjorkman et al (2012) they demonstrate 
through functional magnetic resonance imaging that when the stump is stimulated the 
area that used to contain sensory information for the fingers is still being stimulated. This 
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means that although there is somatosensory cortex restructuring in people with 
amputations, this restructuring is not complete.  
These maladaptive changes can also be found in the primary motor cortex in 
comparing individuals with hand amputation to healthy individuals (Raffin et al., 2016).  
This theory proposes that due to lack of stimulation in these areas, restructuring begins to 
take place. In particular, this causes the primary motor cortex to reorganize itself to 
utilize the under-stimulated area. In the study done by Raffin et al (2016), through 
functional magnetic resonance imaging, they found asymmetries between hemispheres 
for upper limb amputees. Specifically, there was a difference in the lip and elbow areas, 
but not the hand representation. This means that there was cortical reorganization in the 
areas surrounding the hand, where the pain was felt, but no reorganization of the had area 
itself. Furthermore, the less control that the individual had over their phantom limb, the 
more restructuration had taken place. On the contrary, if the individuals felt that they 
could move their phantom hand, they had less topographic changes in the lip and elbow 
areas (Raffin et al., 2016). More topographic changes led to higher intensity of their 
phantom pain.  This adds to the complexity of what mechanisms are forcing the cortical 
reorganization.  
Returning to the idea that there are changes in bilateral mechanisms, it can be 
seen that interhemispheric interactions are also changed after amputation. It has been 
found that there are microstructural changes in the white matter tracts of commissural 
fibers connecting the premotor cortices (Jiang et al., 2015). This means that the cortical 
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restructuring is not limited to just the side that contains information for processing the 
amputations (contralateral), but the opposite side as well.  
To summarize, central nervous system maladaptive plasticity is one of the leading 
theories in regard to phantom limb pain. Changes in the connections of the brain have 
been seen in the somatosensory strip, the motor strip, as well as interhemispheric 
structures. While these theories do a good job of explaining the overall sensation, they do 
not discuss at what point these sensations transform into pain and what causes this change 
to take place.  
Body schema. 
A third theory implements the idea of body schema. Body schema is an internal 
awareness of an individual’s body and the relationship between body parts. This theory 
relates most closely to that of the previous theory involving the central nervous system 
and should be regarded as an expansion on it.  In this theory, there is the belief that there 
is no afferent signaling from the limb, but the central nervous system still believes there 
is based on the neurocircuitry still present (Jerath, Crawford, & Jensen, 2015). Such 
locations of spatial processing could include the parietal lobe. A large amount of work 
done on the body schema theory is theoretical, and few studies have been done proving 
its significance.  
Relief from phantom limb pain can also implicate the body schema theory. One 
study describes a case in which scratching and touching another person’s body or one’s 
own prostheses was helpful in relieving pain which may provide further support for the 
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idea of body schema and image (Weeks & Tsao, 2010).  This study was only a case 
report, but this report implies the potential involvement of the visual system in phantom 
limb pain.  
The rubber hand paradigm is further support for the body schema theory. In the 
paradigm, one believes that the touch that is applied to rubber hand is actually taking part 
in one’s own body (Botvinick & Cohen, 1998). This is due to the simultaneous 
stimulation of one’s own hand, while also committing visual feedback to the hand itself. 
The brain integrates these two events into a single event in which its own hand is being 
touched (Metral, Gonthier, Luyat, & Guerraz, 2017). This illusion provides support to 
why touching another person could relieve phantom limb pain and provides support to 
the body schema theory. A theory that in regards to the phantom limb is mostly 
theoretical.  
 Though body schema theory may be considered an extension of central nervous 
system maladaptivity, this maladaptivity does not necessarily explain how the 
involvement of other individual’s body parts can relieve phantom limb pain.  
Conclusion 
All of these models are conflicting both in theory and in data. At the same time, in 
other places, these theories overlap with similar mechanisms and similar parts of the 
nervous system being described. Still to this day, no exact neurological mechanism has 
been found to fully explain phantom limb pain (Stockburger, Sadhir, & Omar, 2016). 
Further research on phantom limb pain must be done in order to discover the true reason 
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behind it. The next chapter will examine the ways that we treat phantom limb pain, even 
when so little is known about its cause.   
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CHAPTER 2: TREATMENT OF PHANTOM LIMB PAIN 
The following quotation comes from the book Phantoms in the Brain by 
Ramachandran and Blakeslee (1998). Ramachandran was the first to invent and use 
mirror therapy for the treatment of phantom limb pain: 
“To enable patients like Irene to perceive real movement in their nonexistent 
arms, we constructed a virtual reality box. The box is made by placing a vertical 
mirror inside a cardboard box with its lid removed. The front of the box has two 
holes in it, through which the patient inserts her “good hand” (say, the right one) 
and her phantom hand (the left one). Since the mirror is in the middle of the box, 
the right hand is now on the right side of the mirror and the phantom is on the left. 
The patient is then asked to view the reflection of her normal hand in the mirror 
and to move it around slightly until the reflection appears to be superimposed on 
the felt position of her phantom hand. She has thus created the illusion of 
observing two hands, when in fact she is only seeing the mirror reflection of her 
intact hand. If she now sends motor commands to both arms to make mirror 
symmetric movement as she was conducting an orchestra or clapping, she of 
course “sees” her phantom moving as well. Her brain receives confirming visual 
feedback that the phantom hand is moving correctly in response to her command” 
(p. 46).  
As discussed in the previous chapter, the mechanisms behind phantom limb pain 
are poorly understood. Because of this, it makes sense then that the treatment options for 
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phantom limb pain are just as variable in their mechanisms and effectiveness. In a survey 
done on American Veterans over their chronic stump and phantom pain, only 1% of 
participants reported a lasting relief of treatment (Sherman, Sherman, & Parker, 1984). 
This survey demonstrates the ongoing challenge of the treatment of phantom limb pain. 
This chapter will give an overview of the common treatment options for phantom limb 
pain such as medication, injections, and more invasive interventions such as surgery. It 
will then further explore the use of mirror therapy as a treatment. Mirror therapy is one 
effective treatment for phantom limb pain, yet the reason why is not clear.  This chapter 
focus on its use in phantom limb pain, and potential mechanisms for why it is effective.  
 Treatment Options 
Medications 
Medications are a common treatment for phantom limb pain because they are 
minimally invasive and are already prescribed for many types of pain (Everdingen, 
Graeff, Jongen, Dijkstra, & Vissers, 2017; Moura et al., 2018). Some medications that are 
used to treat phantom limb pain include opioids, NMDA receptor antagonists, non-
steroidal, anti-inflammatory drugs, anticonvulsants, and antidepressants (Alviar, Dungca, 
& Hale, 2016).  
Opioids work by mimicking endogenous enkephalins and endorphins. Opioids 
bind onto the receptors for enkephalins and endorphins, modulating the body’s pain 
response. Opioids are prescribed for a variety of chronic pain disorders, and this is why 
they are prescribed for phantom limb pain as well. Opioids have been found to be an 
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effective treatment for relieving phantom limb pain symptoms (Alviar et al., 2016). This 
effectiveness has been found for both oral and intravenous use of morphine for phantom 
pain treatment (Huse, Larbig, Flor, & Birbaumer, 2001; C. L. Wu et al., 2002). Pain relief 
when using morphine was found in up to fifty percent of patients with phantom limb pain 
but was found to be more effective in relief for stump pain (C. L. Wu et al., 2002). Even 
with the effectiveness of opioids in some individuals, common side effects of opioids 
include tiredness, dizziness, sweating, constipation, urination difficulties, nausea, vertigo, 
itching, and shortness of breath (Huse et al., 2001). Furthermore, opioid use carries a high 
potential for addiction. This is particularly relevant for the veteran population who have a 
high comorbidity of other psychiatric illnesses such as post-traumatic stress disorder 
(PTSD; Wilder et al., 2016).  
Another medication that has had found mixed results is NMDA receptor 
antagonists. These drugs decrease the activity at certain receptors within the nervous 
system, called NMDA receptors.  Normally, these receptors cause hyperalgesia, 
neuropathic pain, and reduced functionality of opioid receptors. In regards to a phantom 
limb, these medications block the NMDA receptors in the dorsal horn of the spinal cord, 
which are responsible for the majority of sensitization and hyperexcitability. There are 
different types of these NMDA receptor antagonists, each of which shows differences in 
effectiveness. For example, memantine has been shown to be no different than a placebo 
in relieving phantom limb pain (Mair et al., 2003), whereas dextromethorphan has been 
shown to increase pain relief up to fifty percent, and had very little side effects in the 
study (Abraham, Marouani, Kollender, Meller, & Weinbroum, 2002). While it has been 
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found effective, the length of the study only showed short-term effectiveness, and 
additional research is needed to validate their effectiveness over a longer duration.  
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used 
treatment for phantom limb pain after opioids and acetaminophen (Hanley, Ehde, 
Campbell, Osborn, & Smith, 2006). Typically, NSAIDs work as nonselective inhibitors 
of the enzyme cyclooxygenase (COX) (Sukhtankar, Lee, & Rice, 2014). COX normally 
catalyzes the formation of prostaglandins, a neurotransmitter that transmits pain. Over 
20% of respondents to a survey of those with lower limb amputations responded that if 
they were receiving treatment for phantom limb pain it was with NSAIDs (Hanley et al., 
2006).  Even with the frequency of use, little research has been done on the effectiveness 
of treatment of both acetaminophen and NSAIDs. In the same survey, over half of the 
respondents using NSAIDS ranked their effectiveness as 1 or 2 on a scale of 1-5, which 
represented very little relief as a result of the drug (Hanley et al., 2006). NSAIDs work by 
inhibiting the enzymes needed to synthesize prostaglandin, a neurotransmitter that works 
to increase pain. Acetaminophen has similar effectiveness reported as NSAIDs (Hanley et 
al., 2006). The mechanism of action of acetaminophen is not fully understood, but it is 
believed that it is a weak inhibitor of prostaglandins (similar to NSAIDs), with a different 
mechanism of action (Sharma & Mehta, 2014). Though acetaminophen and NSAIDs are 
commonly prescribed, there is little research other than self-report data on how effective 
they are on relieving phantom limb pain. 
Both anticonvulsants and antidepressants are medications that are normally used 
to treat other disorders, seizures, and depression, respectively (Margolis, Chu, Want, 
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Copher, & Cavazos, 2014; Thase & Schwartz, 2015). Anticonvulsants increase the 
activity of inhibitory neurotransmitters and therefore decrease the overall activity of the 
central nervous system. By doing so, it is thought they can reduce pain, which is normally 
transmitted through excitatory mechanisms, such as by the neurotransmitter glutamate. 
Antidepressants typically increase the concentration of different neurotransmitters, such 
as serotonin, within the central nervous system. While both of these medications are 
sometimes prescribed for phantom limb pain, there is conflicting research supporting 
their effectiveness. One study on the use of gabapentin (anticonvulsant) found the drug 
effective in decreasing phantom limb pain intensity, while another found no difference 
between gabapentin and a placebo (Bone, Critchley, & Buggy, 2002; D. G. Smith et al., 
2005). Due to the paucity of research on these types of drugs with respect to phantom 
limb pain, it is difficult to support their use in the treatment of phantom limb pain. In 
particular, these types of drugs may only be effective in a small group of individuals.  
As outlined above, there are mixed results on how effective medications are in 
treating phantom limb pain. It has been found that there is not one medication that 
effectively relieves pain for all patients. Additionally, it should be noted that these 
medications are not curing the basis of phantom limb pain, but only treating the 
symptoms with varying degrees of success. These medications have a large number of 
adverse side effects, and as such, they should only be used on a patient by patient basis.  
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Noninvasive treatment 
Noninvasive treatment options for phantom limb pain include nerve stimulation, 
acupuncture, and mirror therapy (Mulvey et al., 2010; Trevelyan, Turner, Summerfield-
Mann, & Robinson, 2016; Young Kim & Young Kim, 2012). Mirror therapy will be 
discussed in depth later in this chapter. 
Transcutaneous electrical nerve stimulation (TENS) is a tool for pain management 
that provides short-term relief for people with chronic pain. There are minor side effects 
as compared to other treatments of phantom limb pain such as pharmacological 
interventions. TENS units work to excite/stimulate sensory nerves through an electrical 
current. In doing so, the unit activates natural pain relief mechanisms. It is believed that 
the TENS units target two naturally occurring systems: the pain gate mechanism, and the 
endogenous opioid system. The relationship between frequency and intensity of the 
stimulation and the systems it interacts with, as well as its optimal pain-relieving 
properties, is unclear (Köke et al., 2004). TENS has been found to be an effective 
treatment of stump pain (Mulvey et al., 2010). In this same study, it was shown that 
appropriate electrode placement could evoke TENS sensations in the phantom limb, 
which relieved the pain of phantom limb (Mulvey et al., 2010). Additionally, research has 
shown TENS to be an effective pain management tool for those with phantom limb pain 
(Tilak et al., 2016). It should be noted, however, that the use of TENS does not provide 
long-lasting effects on the pain.  
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It is believed that acupuncture has a similar mechanism of action as TENS in that 
it activates the endogenous opioid system in order to provide pain relief (Housley, 2016). 
Acupuncture involves inserting very thin needles into the skin at strategic points around 
the body. The research done on acupuncture and its effects on phantom limb pain are 
small, coming mostly from case studies and trials. In one such small trial, acupuncture 
was shown to be effective in relieving the maximum intensity of phantom limb pain as 
well as average pain intensity (Trevelyan et al., 2016). Some participants received 
acupuncture in the affected limb, some received it in the contralateral limb, and some 
received it in both. While such results are exciting, it is clear that further research needs 
to be done in order to determine if acupuncture is effective in treating phantom limb pain, 
and which location among these works the best.  
Noninvasive treatments are a promising area of investigation in the treatment of 
phantom limb pain and will be explored further later in this chapter. With this being said, 
there is a lack of knowledge on the exact mechanism of action of these treatments in 
chronic pain, and particularly in, phantom limb pain.  
Minimally invasive treatment 
Minimally invasive treatment options for phantom limb pain consist of spinal 
cord stimulation and injections. In a spinal cord stimulation, through surgery, a spinal 
cord stimulator is placed under the skin and a wire sends a mild electrical current to the 
spinal cord (Eldabe et al., 2015). The electrodes are placed in the dorsal epidural space. 
This is the space above the dura of the spinal cord and below the bone of the vertebrae. 
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When the device is turned on, it stimulates the fibers around the area of the spinal cord 
that is responsible for where the pain is felt. While the mechanism of action of spinal 
cord stimulation is not known, it is proposed to do with either altering the chemical 
transmission of the dorsal root of the spinal cord, or through the activation of dorsal 
column nuclei (Smits, Van Kleef, Holsheimer, & Joosten, 2013).  When looking at 
phantom limb pain, spinal cord stimulation has mixed results (McAuley, Van Gröningen, 
& Green, 2013; Viswanathan, Phan, & Burton, 2010). While patients received the initial 
benefit of pain relief from the insertion of the device, one year and two years following 
the insertion the relief was not as strong (McAuley et al., 2013). Side effects found in 
phantom limb patients with the insertion of the spinal cord stimulator included allergic 
dermatitis to the generator and surgical site infection (Viswanathan et al., 2010). Both of 
these studies were conducted with small sample sizes, and because of this further 
research is needed in order to understand if this treatment should be prescribed to patients 
experiencing phantom limb pain. 
Injections for phantom limb pain work on both the musculoskeletal system and 
the peripheral system. Examples of relief include bupivacaine and lidocaine injections 
which are called nerve blocks. These nerve blocks work by blocking the pain signaling of 
the nerves that innervated the limb. When looking at bupivacaine injections, a small 
study showed relief in phantom limb pain in six out of eight patients (Casale, Damiani, & 
Rosati, 2009). Because this was a small study, further research must be done to determine 
bupivacaine’s effectiveness. The effectiveness of lidocaine on phantom limb pain has 
been examined in injections that also contained Depo-Medrol. Depo-Medrol 
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(methylprednisolone acetate) is a steroid that works on the musculoskeletal system in 
order to relieve inflammation. This study also examined how injections of botulinum 
toxin type A could be used to treat phantom limb pain. In this study, it was found that 
botulinum toxin type A and lidocaine/Depo-Medrol had nearly equal relief of residual 
limb pain (stump pain), but did not work on phantom limb pain (Wu, Sultana, Taylor, & 
Szabo, 2012). While these injections are used in an attempt to target phantom limb pain, 
it seems they have better effectiveness in the relief of stump pain.  
Minimally invasive treatments have mixed results in the treatment of phantom 
limb pain. Both spinal cord stimulation and injections can be seen as an effective 
treatment for relieving stump pain after amputation. They do not, however, seem to be 
effective in the treatment of phantom limb pain. Even though studies done on this 
subtype of treatment are all small studies, their results do not show much promise as a 
treatment.   
Invasive treatment  
Invasive treatment for phantom limb pain includes deep brain stimulation and 
stump revision. These surgeries are intensive and can potentially lead to a large number 
of side effects.  
Stump revision therapy is normally done to facilitate the fitting of a prosthesis 
and/or treatment of a neuroma (Tintle, Baechler, Nanos, Forsberg, & Potter, 2012). 
Stump revision for a prosthesis can be due to skin scarring, the shape of the bone(s), or 
chronic ulcers that inhibit the prosthesis from fitting correctly. On the other hand, a 
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neuroma is a benign growth of nervous system tissue which occurs after irritation or 
injury (amputation in this case). Neuromas typically cause a painful sensation wherever 
they are located. While neuromas are painful, they are not the only source of stump pain, 
and phantom limb pain can exist with or without a neuroma (Zeng et al., 2016). 
Normally, stump revision is not carried out just for the treatment of phantom limb pain. 
The success rate for stump revision is very high when there is a known cause for the pain 
(normally stump pain), but on the flip side is very low when there is no known cause and 
for this reason it is not typically performed only for phantom limb pain (Tintle et al., 
2012). With any surgery, there is the risk of complication such as infection. For these 
reasons, there is very little research on stump revision’s effect on phantom limb pain.  
Deep brain stimulation involves the placement of electrodes deep within the brain. 
These electrodes provide an electrical stimulus to certain areas of the brain and either 
regulate abnormal activity (similar to a pacemaker) or are targeting certain cells to trigger 
the release of specific neurotransmitters (Farrell, Green, & Aziz, 2018). Deep brain 
stimulation is used to treat neurological disorders such as Parkinson’s disease, Tourette 
syndrome, and chronic pain (Daneshzand, Faezipour, & Barkana, 2018; Farrell et al., 
2018; Smeets et al., 2018). In the treatment of chronic pain, deep brain stimulation is 
successful in cases where other treatments such as medications and other more 
conservative measures have proved unsuccessful (Falowski, 2015).  When looking at 
phantom limb pain, in particular, deep brain stimulation in the periventricular grey matter 
and the somatosensory thalamus has shown up to a 60% reduction of the pain (Abreu et 
al., 2017; Bittar, Otero, Carter, & Aziz, 2005). As with most phantom limb pain 
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treatments, these studies have small population sizes, and so further research needs to be 
done. With this being said, deep brain stimulation effectiveness in overall chronic pain 
and in these small phantom limb studies demonstrates its promise.  
 As discussed, an invasive technique comes with more associated risk 
compared to more conservative measures. While stump revision surgery does not seem 
effective in the relief of phantom limb pain (but effective for residual stump pain), deep 
brain stimulation could be considered as a promising treatment. Especially in cases where 
more conservative treatment has proved unsuccessful.  
Mirror Therapy 
 Much of the research on the treatment options for phantom limb pain discussed 
above was conducted with small sample sizes. Additionally, many of these options had 
adverse side effects. For this reason, the remainder of this chapter will discuss mirror 
therapy, which was introduced earlier in this chapter. Mirror therapy is a non-invasive 
treatment option, with very few side effects, that has shown promise in alleviating 
phantom limb pain.  
Description 
In the 1990s, Vilayanur S. Ramachandran invented mirror box therapy, also 
known as mirror therapy or virtual reality box therapy. At the beginning of this chapter, 
the reader was introduced to the details of Ramachandran’s mirror therapy protocol.  
Mirror therapy can be used for both upper and lower limb amputations. Ramachandran’s 
account was that of an upper limb amputation. In an upper limb amputation, the patient 
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places their affected limb on one side of the box, hidden, while their healthy arm is 
placed on the other side. The patient views their healthy arm in a mirror. The patient is 
then instructed to move both arms in a symmetrical pattern. The patient views their 
“phantom” limb moving by looking at the mirror. The thought is that the brain is 
perceiving this mirrored image as the movement of the affected limb, and therefore, it 
reduces the pain eliminating what Ramachandran called “learned paralysis” 
(Ramachandran & Blakeslee, 1998).  Generally, with a lower limb amputation, the same 
methods are performed, except a body length mirror and not a box is utilized.  
The utility of mirror therapy is not limited to individuals with phantom limb pain 
and it has been found to have other uses in stroke and Parkinson’s patients (Bonassi et al., 
2016; Pérez-Cruzado, Merchán-Baeza, González-Sánchez, & Cuesta-Vargas, 2017). In 
these disorders, mirror therapy is employed for improvement in movement as well as a 
decrease in pain. Mirror therapy has been found to increase the motor recovery and motor 
function of upper and lower limb patients affected by stroke (Broderick et al., 2018; 
Pérez-Cruzado et al., 2017). Mirror therapy also increases the speed with which 
individuals move their limbs in Parkinson’s disease (Bonassi et al., 2016). 
In addition to improvement in motor recovery, mirror therapy can improve pain in 
their affected limbs. Following a stroke, individuals can develop complex regional pain 
disorder in their affected limb. In this disorder, individuals experience a throbbing or 
burning pain in the affected limb as well as a decreased pain tolerance in this limb. 
Mirror therapy provides an analgesic relief for patients with complex regional pain 
disorder. It reduces the pain that individuals experience in their affected limb in both 
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intensity and duration (Cacchio, De Blasis, De Blasis, Santilli, & Spacca, 2009). These 
uses of mirror therapy reveal that is a promising technique for use in many neurological 
disorders.  
Effectiveness of Mirror Therapy 
Mirror therapy has been shown to be an effective way to relieve phantom limb 
pain (Timms & Carus, 2015). Mirror therapy has been shown to reduce the pain intensity 
and duration of the pain (Dall et al., 2015; Foell, Bekrater-Bodmann, Diers, & Flor, 
2014). In contrast to some of the treatments outlined earlier, the pain relief was shown to 
extend through the duration of the treatment (Foell et al., 2014). Multiple external 
variables can affect the success of the treatment; for instance, it seems that treatment is 
the most successful for individuals who are not using a prosthesis (Barbin, Seetha, 
Casillas, Paysant, & Pérennou, 2016). Additionally, it appears that the treatment is the 
most successful for individuals who are relieving pain caused by distortional views of 
their phantom limb (Barbin et al., 2016). A distortional view of the phantom limb means 
that the patient feels as if their limb is twisted in an unnatural manner such as backwards 
or warped. It should be noted that mirror therapy does have some side effects, such as a 
vague sense of psychological irritation and confusion (Casale et al., 2009),  
It should be noted that there has been some critique of the treatment of phantom 
limb pain with mirror therapy. While individual studies have demonstrated effectiveness, 
as discussed above, review papers point to heterogeneous methods and nonsignificant 
relief of pain (Barbin et al., 2016; Timms & Carus, 2015). These studies discuss that 
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there are no standardized protocols (such as intensity, length, and duration of treatment) 
being studied in relation to mirror therapy, and because of this, its effectiveness cannot be 
effectively evaluated. Additionally, the treatment is critiqued due to lack of lasting pain 
relief. The relief normally subsides after the treatment concludes (Timms & Carus, 2015). 
With this being said, this treatment could be relatively simple for an individual to 
continue to perform on their own, in comparison to some of the invasive and 
pharmacological treatments discussed earlier.  
Another aspect of mirror therapy that needs to be investigated further is agency. 
Agency may further explain the discrepancies in treatment pinpointed by the review 
papers. Mirror therapy seems to increase the agency that the individual has over their 
missing limb and the pain in most cases of treatment (Imaizumi, Asai, & Koyama, 2017). 
This increase is most likely due to the congruence of the predicted movement pattern, and 
actual sensory feedback that agreed with this prediction. Individuals who feel that they 
have control over their affected limb have higher rates of pain relief. This sense of agency 
may be a future direction in explaining the incongruence between why mirror therapy 
works for some, but not all individuals experiencing phantom limb pain. Another area of 
investigation ought to be whether there are extrinsic ways to improve agency in 
individuals, or if this is an intrinsic characteristic of the individual.  
While it seems that mirror therapy can be an effective mechanism of pain relief 
for individuals with phantom limb pain, it does have some side effects. These side effects 
are relatively minor compared to other types of treatment discussed in this chapter. 
Furthermore, there needs to be more research on what type of protocol works when it 
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comes to mirror therapy. With all this being said, the effectiveness of treatment should be 
looked at on a patient by patient (or case by case) basis.  
Mechanisms 
 Like many treatments of phantom limb pain, the mechanisms of mirror therapy 
are unclear. One of the main mechanisms that has been proposed for mirror therapy 
involves mirror neurons. A mirror neuron is a neuron that fires both when an animal 
performs an action and when the animal sees another perform the same action. These 
motor neurons were first discovered in the ventral premotor cortex (F5) of the macaque 
monkey (Rizzolatti & Craighero, 2004). Some other areas in which mirror neurons have 
since been found are the dorsal premotor cortex, parietal cortex, and the primary motor 
cortex (Lee et al., 2018). These locations are anatomically connected to the premotor 
cortex.  As such, it can be seen that the main role of mirror neurons is thought to be the 
planning and execution of movement after it has been seen. As such, it has been 
hypothesized that mirror neurons have to do with associative learning and it should be 
noted that mirror neurons are most likely also involved in somatosensation due to their 
existence in the parietal lobe. 
 In mirror therapy, it is thought that mirror neurons are triggered when the 
individual sees the reflection of their limb in the mirror (Finn et al., 2017; Timms & 
Carus, 2015). Because of this, the individual then feels the same sensation as if they were 
actually moving the limb. The individual does not receive any input from touch receptors 
telling them otherwise, as they do not exist. Mirror neurons would then modulate the 
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somatosensory inputs being received by the brain, and, for this reason, eventually 
decrease the level of phantom limb pain that the individual perceives. 
 There are some problems with the implications of the involvement of mirror 
neurons in mirror therapy. This is due to the fact that mirror neurons are normally thought 
to be involved in goal-oriented behavior that involves the hand and/or facial expression. 
Specifically, they are thought to be involved in associative learning with these 
expressions or movements. These functions do not explain, however, how they would be 
involved in movements of other limbs such as the lower limbs, which mirror therapy also 
works on. Such conclusions are also due to the fact that most research done on mirror 
neurons involve these actions (Ferrari, Gerbella, Coudé, & Rozzi, 2017). Because of this, 
further research needs to be done to elucidate whether they are activated with the 
movement of other extremities.  
 Due to the fact that the mirror neuron system is not fully understood, and recently 
discovered, it is difficult to understand the system’s full role in mirror therapy.  
New Technology 
 Dr. Ramachandran himself discusses that when he invented the treatment 
technique, he could imagine virtual reality systems. In his book Phantoms in the Brain: 
Probing the Mysteries of the Human Mind he states, “I thought about virtual reality. 
Maybe we could create the visual illusion that the arm was restored and obeying her 
commands. But that technology, costing over half a million dollars, would exhaust my 
entire research budget with one purchase,” (Ramachandran,1998, p. 46). Recently, virtual 
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reality systems have come to the forefront of the research being done to treat phantom 
limb pain.  
 Typically, in a virtual reality set-up, individuals wear a head-mounted display. 
Through this display, individuals are shown a mirror-reversed computer graphic image of 
an intact arm. This means that they “see” their phantom limb when they look down. 
Similar to mirror therapy, individuals are asked to move both their arms in a similar 
movement pattern, such as a circle. In a study of eight patients, virtual reality 
significantly decreased individuals pain scores (Osumi et al., 2017). Furthermore, a 
different study applied tactile stimulation to the same side cheek as the phantom limb, the 
intact limb, and a no stimulation control group. Individuals were asked to “touch” objects 
that appeared in the virtual reality display. Stimulation was applied through vibration, 
similar to that found on a mobile phone. They found that the group where stimulation was 
applied to the cheek had the largest reduction in pain compared to the other two groups, 
but there was a reduction of pain in all three groups (Ichinose et al., 2017). As described 
in Chapter 1, the face and arm areas are near each on the sensory and motor homunculus, 
which may help explain why facial stimulation could enhance pain relief (Snyder & 
Whitaker, 2013). Via central nervous system plasticity, the areas previously devoted to 
the arm may have been encroached upon by the areas devoted to the face, potentially 
explaining how cheek stimulation would increase the analgesic effect.  
 Even with this said, there is isn’t enough research on virtual reality to justify the 
investment over mirror therapy at this point.  The research on virtual reality systems has 
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been on a small study or case study basis. While virtual reality could be a promising area 
in the future, at the current time there is not enough research to justify its use.  
Conclusion 
This chapter shows that there is a wide range of treatments available for phantom 
limb pain, yet none are effective for everyone with the disorder. The majority of this 
chapter was spent discussing mirror therapy and its potential mechanisms due to the fact 
that it is the only treatment for which use was developed originally for phantom limb pain 
(Ramachandran & Blakeslee, 1998).  For this reason, mirror therapy can be utilized as a 
way to further investigate the potential sources of phantom limb pain.  Looking forward, 
the next chapter will examine the treatments of phantom limb pain described in this 
chapter through a bioethical lens.   
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CHAPTER 3: BIOMEDICAL ETHICS OF TREATMENT 
As discussed in the previous chapters, the treatment of phantom limb pain is very 
difficult. Not only are the mechanisms behind phantom limb pain not well understood, 
but there is no form of treatment that is effective for everyone. As such, the implications 
of treating this disorder must be discussed. This chapter will begin with an overview of 
common ethical principles that will guide the discussion of the treatment of phantom 
limb pain. The chapter will then outline a framework to guide clinicians through the 
treatments of phantom limb pain based on the one provided by Largent (2009) in the 
article, “Going off-label without venturing off-course: evidence and ethical off-label 
prescribing” to examine the ethicality of phantom limb pain treatments.  
Biomedical Ethics Overview 
While there are many approaches to biomedical ethics, this chapter will focus on a 
dominant approach which centers around four main principles. This approach is called 
the common morality principlism and is an effort to resolve issues that arise in clinical 
practice. Principles of Biomedical Ethics by Tom Beauchamp and James Childress 
(2009) explores these directing principles and their implications. The directing principles 
are as follows: principle of respect for autonomy, principle of nonmaleficence, principle 
of beneficence, and principle of justice (Beauchamp & Childress, 2009). While 
Beauchamp and Childress maintain that these principles are not absolutes, they can be 
weighed and balanced in order to create guidelines in clinical decision makings.  
 33 
 
Moreover, these principles are not ranked in any way, but instead, need to be utilized 
differently depending on the clinical situation.   
Principle of respect for autonomy 
 Autonomy is generally thought of as a state of self-governance by a group of 
people or institution (Autonomy, 2019). The respect for autonomy can be applied to 
individuals. Generally, patients should be thought of as independent beings who have the 
ability to make their own decisions so long as they are sufficiently autonomous. 
Autonomy is arguably the moral basis behind informed consent (Stoljar, 2011). The 
elements of informed consent are as follows: (1) the patient must have decision-making 
capacity, (2) the patient must receive full disclosure of the treatment, (3) the patient 
should understand the treatment, (4) the act must be voluntary, and (5) patient consent 
must be obtained (Beauchamp & Childress, 2009).   
The principle of autonomy is deeply interwoven with the practice of informed 
consent. Informed consent allows practitioners to protect the autonomy of their patients 
as well as those who are not autonomous. Individuals must have decision-making 
capacity in order to make reasonable treatment options (directed by a physician) for 
themselves. If the conditions outlined above are not met, the patient cannot consent to 
their treatment.  
Principle of nonmaleficence 
 The principle of nonmaleficence is based on the idea of the Hippocratic oath 
which states “do no harm” (Boodt, 2004). In other words, Beauchamp and Childress 
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(2009) define this principle as “one ought not to inflict evil or harm” (p. 151). Within a 
health care setting, the health care provider has an obligation to refrain from doing any 
unjustified harm to the patient. This is known as the harm-benefit ratio. Sometimes, harm 
can be associated with the treatment. Practitioners need to have the ability to balance 
many moral considerations in order to effectively treat a patient (Beauchamp & 
Childress, 2009). Sometimes, the patient and the family of this patient may see the 
benefits and risks differently than the practitioner, and for this reason, they need to be 
able to see all individuals’ viewpoints.  
Principle of beneficence 
 The principle of beneficence requires that health care providers should promote 
good (Beauchamp & Childress, 2009). It refers to the actions that a health care provider 
does in order to benefit their patients. One way that beneficence can be demonstrated is 
through advocacy for protecting and defending patient’s rights. Practitioners should act in 
a way that promotes safety and quality of life for their patients (Chiovitti, 2011). 
Furthermore, this principle demonstrates the idea that the health care provider should not 
deprive the individual of their harmless pleasures in life. While physicians are not 
required to aid these individuals in such pleasures, helping them does fall under the 
principle of beneficence (Beauchamp & Childress, 2009).  
Principle of justice 
 In Beauchamp and Childress (2009) Principles of Biomedical Ethics, the authors 
do not settle on one definition of justice. They choose to look at justice through multiple 
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different theories including utilitarian, libertarian, communitarian, and egalitarian views 
of justice. Through examining these theories, they show that no single definition or 
theory can sufficiently explore medical policy (Beauchamp & Childress, 2009). While 
the previous three principles are more specific to the individual, this principle provides 
insight into the treatment of multiple individuals with similar illnesses, the entire 
caseload of one provider, or health policy at a national and global level (Kiddell-Monroe, 
2014).  
Summary 
The common morality principlism remains the dominant approach in looking at 
clinical practice issues. The four directing principles that Beauchamp and Childress 
(2009) developed are the principle of respect for autonomy, the principle of 
nonmaleficence, the principle of beneficence, and the principle of justice. These four 
principles will guide this chapter’s discussion of the treatment for phantom limb pain.  
The Problem of Pain Treatment 
Over the last two decades, chronic pain has been recognized as a public health 
concern by both people in the medical field as well as the general public (Bostrom, 1997; 
Jacox, Carr, & Payne, 1994). Experts are even going so far as to say that the treatment of 
pain should be considered a global health priority (Goldberg & McGee, 2011).  Severe 
and chronic pain is very common. In one study, nearly half of the respondents reported 
that they had experienced severe pain at one point in their life (Bostrom, 1997). The 
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treatment of all types of pain remains difficult due to the subjective nature of pain (M. P. 
Jensen, Karoly, & Braver, 1986).  
Even though pain is so common, most of the pain management research studies, 
and resulting guidelines, have been for the treatment of cancer pain (Jacox et al., 1994; 
Sullivan & Ferrell, 2005). The most common approach to cancer pain is to increase 
dosages and different types of medications until pain relief is expressed by the patient 
(Jacox et al., 1994). A guideline such as this does not apply to other sources of chronic 
pain; conditions as common as lower back pain, or as rare as phantom limb pain. It is not 
practical, or safe, for individuals to be on high doses of medications that could impair 
their cognitive performance or impact organs for long periods of time (Salvo et al., 2011; 
Sukhtankar et al., 2014).  
To further demonstrate the problem of pain treatment, the clinicopathological 
model of pain should be discussed. In such a model, the physician believes that the 
subjective pain an individual is experiencing is due to an objective lesion (Sullivan, 
1998). As such, physicians seek out a lesion or disease to explain the pain the patient is 
experiencing. Many times, chronic pain does not have an objective cause that physicians 
can accurately point to and measure. For instance, imaging may not display a direct cause 
to lower back pain that improvements can be quantified from. Because of this lack of 
ability to find an objective source of pain, the patient and the physician are both left 
feeling unsatisfied about the treatment (Sullivan, 1998). Even when there is an objective 
cause for pain, there are still problems with pain treatment. In cancer-related pain, a lack 
of pain relief was found when there was a discrepancy between the physician’s and the 
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patient’s estimate of the severity of the patient’s pain and its interference with daily 
activities (Cleeland et al., 1994). This demonstrates that all types of chronic pain are 
subject to inconsistencies during treatment. 
Another problem with pain treatment is the scales that are used to evaluate a 
patient’s pain. Three common scales are the Visual Analogue Scale, the Verbal Rating 
Scale and the Numerical Rating Scale (Williamson & Hoggart, 2005). Each of these 
scales asks patients to rate their level of pain as indicated by a mix of verbal and numeric 
descriptors. While these scales provide an easy way to assess the pain of the patient, it is 
hard for the physician to interpret the scales (Williamson & Hoggart, 2005).  These scales 
are valid constructs to measure pain, but they do not show the whole picture. These scales 
only provide information on the intensity of the pain, not the nature of the pain, or how it 
is directly impacting the patient’s life. Additionally, the measurement of pain is 
individualized. For example, one patient’s four on the numerical rating scale could be 
another person’s seven on this same scale. For these reasons, sometimes the best 
measurement of pain is a belief in the patient (McCaffery & Beebe, 1989).  
Making pain treatment even more complex, a large amount of a patient’s 
relationship to their pain is subjective. Not only does the perceived pain vary from person 
to person, as discussed earlier, but the intensity can also be altered due to perceived 
damage that the pain might cause to the individual (Arntz & Claassens, 2004). This 
means that if the individual believes the pain is associated with tissue damage (such as in 
cancer) they tend to perceive and rate the intensity of the pain higher (Arntz & Claassens, 
2004). Additionally, the intensity of a patient’s pain can change due to the meaning of the 
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pain to the individual (Arntz & Claassens, 2004). Meaning can be altered by the emotions 
that the individual has toward the pain such as with traumatic events associated with the 
pain (Ravn, Vaegter, Cardel, & Andersen, 2018). To make things even more complex, 
with most chronic pain, there is a high comorbidity of depression and other mental illness 
(Benjamin, Barnes, Berger, Clarke, & Jeacock, 1988). Such comorbidity with mental 
illnesses, such as depression, is thought to be due to neurobiological components shared 
between the two, such as a reduced level of serotonin (Boakye et al., 2016). The way that 
the individual perceives pain can be influenced by their mental health, as well as how the 
pain is presented to them.  
When we turn to look at phantom limb pain, it can be seen why the measurement 
and treatment of this pain is so difficult. First, there is no physical evidence of the pain 
when the cause is phantom limb pain. These patients have an objective lesion when 
looking at their amputation, but this lesion only explains stump pain. Second, as 
discussed in Chapter 1, the mechanisms behind this pain are not understood (L. 
Nikolajsen & Jensen, 2001; Richardson, 2010; Stockburger et al., 2016). Third, many of 
the patients that experience phantom limb have had traumatic events that may lead to 
alterations in the way they view their pain (Cavanagh, Shin, Karamouz, & Rauch, 2006; 
Desmond & MacLachlan, 2006). Fourth, just as with other types of pain, there does not 
seem to be an objective measurement for the phantom limb pain.  
Phantom limb pain is just a small subset of the pain disorders that need to be 
discussed, but it will remain the focus of this chapter. Choosing the correct treatment for 
phantom limb pain is difficult for physicians, as no one treatment exists to cure the pain. 
 39 
 
For this reason, this chapter will provide a framework modified from “Going off-label 
without venturing off-course: evidence and ethical off-label prescribing” by Emily 
Largent (2009) in order to weigh the risk and benefits of the common treatments 
described in the previous chapter to better help clinicians evaluate different treatments for 
phantom limb pain.  
Biomedical Ethics in Phantom Limb Pain 
Framework Provided in “Going off-label without venturing off-course: evidence 
and ethical off-label prescribing” by Largent (2009) 
 In Largent’s (2009) article, she examines how clinicians should prescribe off-
label drugs. Largent (2009) creates these guidelines because there is “very little guidance 
to distinguish clearly between off-label uses that are well supported by evidence and 
those that are not,” (p. 1745). An on-label use of a drug is the utilization of a drug for its 
FDA approved purpose (Aronson & Ferner, 2017). Off-label use is one in which the drug 
is not being used for its approved labeling use (Largent, 2009).  While the off-label drug 
has already obtained FDA approval, it is being used outside of its approved use. For 
example, this would be a drug that is approved to treat breast cancer (on-label use) but is 
used by a physician to treat lung cancer (off-label use). Off-label drugs present a number 
of practical and ethical issues for physicians because they are often used with a very 
limited amount of information about their efficacy in the conditions for which they have 
not been approved. Practically speaking, strict clinical guidelines are given for a drug 
when it is being used on-label. For example, in on-label use, side effects can be easily 
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identified and discussed with the patient.  On the contrary, when a drug is being used off-
label, new adverse side effects may arise when being used in a new disorder. Further 
ethical issues come forth with off-label use because clinicians must decide how much 
information to disclose to their patient about off-label uses. For these reasons, Largent 
(2009) develops a framework in order to aid physicians in the clinical decision-making 
process when using off-label drugs.  
 Signals for scrutiny.  
There are four categories that the article presents in order to signify more rigorous 
scrutiny of the off-label use which include (1) New Drugs, (2) Novel Off-Label Use, (3) 
Drugs with Known Serious Adverse Effects, and (4) High-Cost Drugs (Largent, 2009). 
These characteristics are outlined in more detail below:  
 (1) New Drugs: These are drugs that have been approved by the FDA, but have 
been on the market fewer than 3-5 years. Drugs such as this have few clinical trials and 
high-quality studies proving if they work. Additionally, it is only after many years on the 
market that all the adverse side effects are seen, especially those that result from the long-
term use of a drug.  
 (2) Novel Off-label Use: This is a new or unusual use for an FDA approved drug. 
This is dissimilar to the cancer example provided above because in that example the drug 
was being used for similar treatment, another form of cancer. Novel off-label use refers to 
a new use of the drug that might be on its own, or in combination with others, in which 
unknown side effects are likely to arise. For example, a drug in this category may have 
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been FDA approved for high blood pressure, but is being used off-label for an unrelated 
condition such as multiple sclerosis.   
 (3) Drugs with Known Serious Adverse Effects: These drugs need to be strictly 
monitored because they have a large risk of serious adverse side effects. While these 
drugs might be justified, dependent on the disorder, most of the time their risk outweighs 
their benefit.  
 (4) High-Cost Drugs: These drugs are expensive in terms of monetary value. 
While they might be highly effective in off-label use, they would be costly to the patient. 
 These signals of scrutiny should be used in order to demonstrate that the off-label 
prescription of these drugs needs further investigation. 
 Evidentiary categories.  
  Further investigation of these drugs should be done by examining the evidence of 
their net benefit. Largent (2009) outlines evidentiary categories and the recommendation 
for prescription provided in the chart below: 
Table 1 
 
Therapeutic Consent Recommendation based on Evidentiary Category 
Category  Evidence Recommendation  
Supported Moderate-high level of certainty 
of net health benefit 
 
Routine therapeutic 
consent 
Suppositional Low level of certainty of net 
health benefit 
 
Augmented therapeutic 
consent 
Investigational Very low level of certainty of net 
health benefit 
Clinical trial/research only 
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Supported. 
In this category, there is evidence from high-quality studies that the drug will 
have an increase in net health benefit. In other words, there is a large number of potential 
benefits as compared to potential harms. The potential harms and benefits of these drugs 
are supported by high-quality studies. For example, within these studies, there is a large 
number of participants and randomized control (Sawaya, Guirguis-Blake, LeFevre, 
Harris, & Petitti, 2007). Largent (2009) recommends that routine therapeutic consent be 
done when prescribing this drug. In other words, the consent process should be treated as 
if it was of on-label use. The processes of informed consent that were discussed at the 
beginning of this chapter should be followed.  
Suppositional. 
 This category has a low level of certainty of net benefit. This could be because of 
a higher potential for harm than benefit from the drug. It could also be because the drug’s 
efficiency is not well supported by high-quality studies. Suppositional evidence requires 
what Largent calls augmented therapeutic consent (2009). While the components of 
informed consent remain, there should be more disclosure than commonly provided when 
prescribing an on-label drug. Furthermore, the physician should communicate the 
uncertainties in terms of both potential risks and potential benefits. This type of 
disclosure should allow more room for the patients’ beliefs.  
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Investigational.  
In this category, there is a very low certainty of net benefit. This means there is 
high risk associated with the drug, with low benefit, as well as very little evidence to 
support its use. In other words, a physician should prescribe this drug under research 
protocols only. She argues that these drugs require the formality of written informed 
consent (Largent, 2009). 
Framework for Phantom Limb Pain 
Largent’s framework provides a place to start when discussing the treatment of 
phantom limb pain. While Largent’s framework is dealing with off-label drug use, I 
argue that her framework can be helpful for the treatment phantom limb pain because 
none of the treatments for phantom limb pain are FDA approved specifically for use in 
the phantom limb. Furthermore, currently, there is limited research and evidence that 
support these treatments’ use in phantom limb pain. The evidentiary categories that she 
provides will be the focus in the discussion of the treatment of phantom limb pain, as 
each of the treatments discussed in chapter two will be placed in one of the categories. 
With this being said, there are cases when the signals for scrutiny will also find their way 
into the discussion.   
The first change that will be made is no longer will the discussion be limited to 
that of off-label drug use. Instead, this discussion will be expanded to all treatments 
available for phantom limb pain. Treatments, just like drugs, have potential benefits as 
well as potential harms associated with them.  All treatments available for phantom limb 
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pain are off-label use because none of them are FDA approved. Moreover, these 
treatments were not originally designed for the treatment of phantom limb pain (with the 
exception of mirror therapy), but for other forms of chronic pain (such as with opioids) or 
other disorders that do not involve pain (such as antidepressants).  
Another change that will be made from Largent’s evidentiary categories is the 
expansion of the suppositional category. As the discussion progresses, it will be argued 
that the majority of phantom limb treatments fall into this category due to the low level of 
support present for the treatments. The following chart below will be used to evaluate 
these treatments: 
Table 2 
 
Order of Use in Suppositional Category Based on Cost and Risk 
Level of Risk Level of Cost Order of Use 
Low Risk Low Cost 1st Line 
Low Risk  High Cost 2nd Line 
High Risk Low Cost 3rd Line 
High Risk High Cost 4th Line 
  
In what follows, I will present a clinical tool for practitioners to help them 
navigate these treatment options with their patients.  The order of use is the order in 
which the treatment options should be presented to their patients. The first line are those 
treatments that should be prescribed and tried first, the second line should be prescribed 
second and so on. The categories of risk and cost are chosen to further evaluate these 
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treatments due to the bioethical principles discussed at the beginning of this chapter. I 
argue that risk needs to be evaluated due to the principle of nonmaleficence. Physicians 
should be prescribing drugs first that do not harm the patient. Additionally, cost needs to 
be evaluated due to the principle of beneficence and the principle of justice. The 
physician ought to provide the least costly treatment first in order for more patients to 
have access to treatment. Moreover, by examining cost, the physician is taking into 
account the other financial responsibilities that the patient may have to themselves or to 
their families. Another reason this framework examines cost because high cost is also one 
of the signals for scrutiny that Largent (2009) provides for off-label use.   
Phantom Limb Pain Treatments  
Below, I fill in the charts provided in accordance with the types of treatments that 
are available for phantom limb pain. Even though clarifications for the rankings will be 
provided, chapter two should be referred to for more in-depth descriptions and studies of 
the treatments. It should also be noted that while not all categories are filled in, it is 
important for them to be present in case a new treatment becomes available.  
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Evidence Labels. 
Table 3 
 
Phantom Limb Treatments Placed in Evidentiary Categories 
Evidentiary Categories Treatments 
Supported None 
 
 
 
 
Suppositional  Mirror Therapy 
Opioids 
NMDA Receptor Antagonists 
NSAIDs 
Acetaminophen 
TENS Unit 
Spinal Cord Stimulation 
Bupivacaine 
 
Investigational 
 
Anticonvulsants 
Antidepressants 
Acupuncture 
Botulinum toxin type A 
Lidocaine 
Spinal Cord Stimulation 
Stump Revision 
Deep Brain Stimulation 
  
At the current time, no treatment exists for phantom limb pain that falls under the 
supported category. This is because, currently, all of the research done on the treatment 
of phantom limb pain includes small numbers of participants, case studies, and 
conflicting evidence (Alviar et al., 2016; Ehde et al., 2000; Pérez-Cruzado et al., 2017). 
For this reason, no treatments have a moderate to a high degree of certainty of net benefit.  
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 In terms of the investigational category, anticonvulsants, antidepressants, 
acupuncture, botulinum toxin type A, and lidocaine have all been placed category due to 
their conflicting research and limited support for pain relief (Alviar et al., 2016; Bone et 
al., 2002; Trevelyan et al., 2016; H. Wu et al., 2012). Additionally, drugs such as 
anticonvulsants and antidepressants fall under the novel off-label use category because 
their approved labeling is not involved in pain management (Bone et al., 2002; Hall, 
Carroll, & McQuay, 2008). 
 Looking further into the investigational category, stump revision, spinal cord 
stimulation, and deep brain stimulation have been placed here due to their high potential 
for harm and low potential for net benefit. Additionally, all three of these treatments are 
surgical, and thus are high in cost (Bell, Mathieu, & Racine, 2009).  Due to this high cost, 
they fall under the signal for scrutiny of drugs (or treatments). Additionally, surgical 
treatments have known adverse side effects. Stump revision surgery is successful in 
relieving stump pain by removing neuromas and other causes of the pain but sees very 
little success in the relief of phantom limb pain (Tintle et al., 2012). As with any surgery, 
there can be adverse side effects in the way of various complications including infection, 
blood clots, reaction to anesthesia, and many others (Tintle et al., 2012). Spinal cord and 
deep brain stimulation have a large degree of potential harm for these same reasons with 
the additional confound that they involve implantation of an electrode in the brain or 
spinal cord  (Abreu et al., 2017; Maslen et al., 2018; Viswanathan et al., 2010). Each of 
these is not well researched in terms of phantom limb pain but has been successful in the 
relief of other types of chronic pain (Farrell et al., 2018; Smits et al., 2013). For these 
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reasons, I argue that these treatments should be reserved for prescription after the 
suppositional categories have failed to treat the patient’s symptoms and these treatments 
should be performed in a research setting only.  
Suppositional Expanded.  
Table 4 
 
Suppositional Treatments for Phantom Limb Pain in Order of Use 
Order of Use Treatments 
1st  Mirror Therapy 
TENS unit 
 
2nd  
 
NMDA Receptor Antagonists 
NSAIDs  
Acetaminophen 
 
3rd 
  
 
None 
 
4th  Bupivacaine 
Opioids 
  
The treatments that I have placed in this category span a wide range of options 
from medication to injections or physical therapy. In general, these are the most 
commonly used treatments for phantom limb pain, and for these reasons they have the 
most research available. However, most of the indicators are not from randomized or 
double-blind trials, but rather patient surveys (Baron, Wasner, & Lindner, 1998; L. 
Nikolajsen & Jensen, 2001).  
Starting from the bottom and looking at the fourth line of use, both an injection 
and opioids are fairly expensive, especially if the patient does not have insurance (Zezza 
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& Bachhuber, 2018). Bupivacaine requires a professional for the injection, and opioids 
require a lifetime prescription. Additionally, these medications have a relatively high 
potential for harm as compared to others in the suppositional category. For example, 
bupivacaine can cause permanent numbing if injected wrong (Nikolajsen, Ilkjaer, 
Christensen, Krøner, & Jensen, 1997). For opioids, they have numerous adverse side 
effects including addiction, dizziness, nausea, etc. (Wilder et al., 2016). 
Currently, there are no treatments in the third line of prescription which are high 
risk and low cost. Moving up to the second line of use, many of the common 
prescriptions for phantom limb pain can be found including NSAIDs and acetaminophen  
(Stockburger et al., 2016). Low-cost versions of these drugs can be found over the 
counter placing them into this category. In terms of risk, both drugs have potential harms 
such as liver failure, gastrointestinal and cardiovascular problems (Hanley et al., 2006; 
Salvo et al., 2011).  
The two treatments that fall into the low risk and low-cost category are 
transcutaneous electrical nerve (TENS) units and mirror therapy. These two treatments 
have some research demonstrating their ability to decrease phantom limb pain (Tilak et 
al., 2016). Additionally, after being taught how to perform mirror therapy or how to use a 
TENS unit by a physical therapist, the individual can perform the therapy whenever they 
want with little cost to them (Mulvey et al., 2010; Pérez-Cruzado et al., 2017). One 
differentiating factor between the two treatments is that TENS unit alleviates the pain for 
only a short duration (hours), while mirror therapy has some potential for its effect to last 
longer (days; Casale et al., 2009; Köke et al., 2004) 
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What This Means for the Prescription of Treatment 
 In the midst of not understanding the mechanisms behind phantom limb pain, 
medications have found themselves at the forefront of pain treatment (Stockburger et al., 
2016). As we return to biomedical ethics principles, increased prescription of in pain 
medication (often in increasing dosage) in those with phantom limb pain prior to trying 
less risky alternatives goes against the principle of nonmaleficence. In these cases, the 
health care provider is potentially doing the patient more harm than good when there are 
other options available. 
The previous chapter went into great depth on the treatment of phantom limb pain 
with mirror therapy.  It can be seen from the framework provided why this is so. For one, 
mirror therapy is relatively inexpensive. While mirror therapy must be done with a 
physical therapist for a few sessions, after learning how, a patient can perform the 
technique by themselves. If effective, this decreases the cost of the treatment compared to 
other traditionally prescribed options such as opioids. As such, mirror therapy follows the 
principle of beneficence in treatment. If the treatment is successful, they can return to 
their daily activities with very little monetary cost to them and avoid the risky side effects 
of opioids such as addiction, nausea, etc. Furthermore, this increases the number of 
individuals who have access to the treatment, and for this reason, follows the principle of 
justice. 
Looking further into the principle of justice, these individuals are often from a 
vulnerable population. As discussed earlier, mental illness is frequently comorbid with 
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chronic pain (Benjamin et al., 1988). Furthermore, those with phantom limb pain are 
even more vulnerable due to the fact that their pain can be associated with a traumatic 
event (Cavanagh et al., 2006; Desmond & MacLachlan, 2006). Prescription of opioids 
could make their condition worse if they are suffering from post-traumatic stress disorder 
or depression (K. Z. Smith, Smith, Cercone, McKee, & Homish, 2016).  Because of this, 
treatments with less risk associated with them should be considered first when looking at 
the phantom limb population.  
While I have argued for low-risk and low-cost treatment options to be presented 
and discussed with the patient first, just like in Largent’s (2009) framework, I maintain 
that the choice should be up to the patient.  The framework that is provided is one that 
clinicians can turn to when prescribing treatment for phantom limb pain. I maintain that 
the treatments should be presented in the order described by the framework, but the 
framework should not be the only viewpoint that the clinician should examine. In other 
words, the clinician should consider the patient’s opinions when making treatment 
decisions. This is based on the principle of respect for autonomy. As described earlier, 
the patient understands their pain and their own risk aversion better than anyone else 
(McCaffery & Beebe, 1989).  
Phantom limb pain, and is treatments are not well understood, and the patient 
should understand this concept. Because all of the treatments available for phantom limb 
pain currently fall in the suppositional category, a clinician should have a conversation 
with the patient that discloses all the risks and benefits of the treatment being provided.  
The patient should work with the physician to recognize the harm-benefit ratio for any 
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treatment. This ratio, which falls under the principle of nonmaleficence, may be weighed 
differently in the patient’s eyes. If the patient decides they want to take a more drastic 
approach, due to the intensity of their pain or some other reason, similar discussions 
should take place as they move down the lines of treatment. In order to ensure the patient 
receives this type of treatment plan, a further recommendation of a team-based approach 
to treatment needs to be discussed.  
Practical Recommendation 
To ensure that patients receive information about multiple treatments and 
understand the harm-benefit ratio of each, more voices should be brought into the 
treatment of phantom limb pain.  While cancer pain and phantom limb pain are two very 
different types of pain, as discussed earlier, they are both subjective experiences which 
are similar in the fact that they are both complex in their mechanisms and treatment (L. 
Nikolajsen & Jensen, 2001; Robb et al., 2010). For this reason, this section will use one 
of the guidelines put forth by cancer pain treatment that could aid in the treatment of 
phantom limb pain.  
Team-Based Approach 
One guideline set forth for cancer-related pain, but seems to be lost in the 
treatment of phantom limb pain, is “a collaborative, interdisciplinary approach to the care 
of patients” (Jacox et al., 1994, p. 651). With this collaborative approach, an 
individualized treatment plan for the patient can be created. The patient can be actively 
engaged in their treatment plan because they are thought of as a member of the team. For 
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the purposes of this discussion, it can be assumed that most individuals with phantom 
limb pain meet the criteria discussed above for informed consent. This is due to the fact 
that most of these patients’ comorbidities with amputations are of a physical nature 
(Foote et al., 2015; Wukich & Pearson, 2013).  For this reason, this approach to treatment 
increases the autonomy a patient has throughout their treatment. A patient receiving 
treatment for cancer pain has not only an oncologist on their team, but a pharmacologist, 
physical/occupational therapist, and psychiatrist/psychologist. Similar to this cancer 
guideline, this approach is currently being expanded to the treatment of other chronic 
pain disorders (Gatchel, McGeary, McGeary, & Lippe, 2014). In the treatment of 
phantom limb pain, I believe that there are two key voices that are not present: a 
psychologist and a physical therapist. These two core positions can increase the principle 
of beneficence in these patient’s care. Both positions serve as key advocates for patient 
safety and wellbeing. 
Psychologist/Psychiatrist 
 I recommend a psychologist/psychiatrist joining the team due to the likelihood of 
patients developing a mental illness while experiencing phantom limb pain (Ahmed et al., 
2017). In the interdisciplinary team, a psychologist’s role is to “provide a full 
psychosocial evaluation” and “Assess [the] patient’s psychological strengths and 
weaknesses” (Gatchel et al., 2014, p. 124). In doing so, the psychologist is examining the 
mental health of the individual and helping them through any mental illnesses they may 
have. In regards to patients with phantom limb pain, there is an increased prevalence of 
depression that should be addressed by a psychiatrist (Ahmed et al., 2017). Specifically, 
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body image and decreased self-esteem in these patients could play a role in this 
depression for individuals (Atay, Turgay, & Atay, 2014). While this particular article by 
Atay, Turgay, and Atay (2014) finds the relationship between decreased self-esteem and 
depression with individuals using a prosthesis, it can be assumed that there is a similarity 
without prosthesis use. Because pain interpretation is, in part, emotionally based, and due 
to the high comorbidity of depression, phantom limb pain patients should have a 
psychologist/psychiatrist on their team as well.  
Physical Therapist  
I recommend a physical therapist to join the team in the treatment of phantom 
limb pain. While physical therapists are commonly utilized in the treatment of amputees 
during prosthesis training, they should further provide a role in pain management (Cole, 
2003). It should be noted that phantom limb pain is not the only pain experienced by 
patients after an amputation. They can also experience stump pain, which is coming from 
amputation (T. S. Jensen et al., 1983). A physical therapist can encourage the treatment 
of these pains through noninvasive techniques. Some techniques that could be suggested 
include a transcutaneous electrical nerve stimulation (TENS) unit or mirror therapy 
(Tilak et al., 2016). These treatments provide an alternative for any patient, but 
particularly those who do not want to become dependent on medications or endure drastic 
measures for the alleviation of their pain.  
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Summary 
In implementing a team-based approach to treatment, the respect for autonomy for 
the patient in their treatment will be increased. The voices of a psychologist/psychiatrist 
and a physical therapist will provide better treatment for phantom limb pain. These voices 
will aid in providing different explanations for the reasons behind the pain, as well as 
treatment options beyond the medications commonly provided. As such, the patient will 
have a more positive and ethically informed treatment experience.   
Conclusion 
 This chapter began with introducing common morality principlism, which served 
as an introduction to bioethical theory. The chapter then introduced the problem with pain 
treatment in general but narrowed down on the specifics of phantom limb pain treatment. 
In order to examine the treatments that exist, and the treatments that may come forth, a 
framework based on the framework presented in “Going off-label without venturing off-
course: evidence and ethical off-label prescribing” by Largent (2009) was presented. 
This, in conjunction with common morality principlism, allowed the ethical evaluation of 
the treatments available for phantom limb pain. While this is just one way to examine 
phantom limb pain, it provides a framework to help guide clinicians through the 
treatments of phantom limb pain. This framework argues that the first treatment that 
should be presented to a patient is that of mirror therapy, with other noninvasive 
treatments and medications to be presented subsequently. With this being said, the 
framework is just a tool, and the choice should be ultimately up to the patient. This 
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evaluation of treatment further highlighted the need for an interdisciplinary team, 
including a psychologist/psychiatrist and physical therapist in order to effectively treat 
this complex disorder.  
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CONCLUSION AND REFLECTIONS 
As we look forward from this exploration of phantom limb pain and its treatment, 
I would like to make some concluding remarks. First, I would like to explore what I see 
as a potential cause of phantom limb pain and how this could be examined in a research 
setting. Secondly, I would like to broaden what the treatment of phantom limb pain 
means for the investigation and treatment of other disorders. In particular, I would like to 
explore how this thesis has changed the way I think of treatment as I soon approach the 
next portion of my education, pursuing my degree as a Doctor of Physical Therapy.  
The Visual Side of Phantom Limb Pain 
In his book Phantoms In The Brain, Ramachandran (1996) discusses the impact 
of visual feedback on phantom limb pain. Ramachandran explains that the brain is 
sending out signals for the amputated limb to move, but the brain does not receive any 
sensory or visual feedback that the arm is actually moving. After this repeated signaling 
the brain comes to a state of “learned paralysis” as the inability to move is “stamped onto 
the brain’s circuitry” (Ramachandran & Blakeslee, 1998, p. 46). In other words, the brain 
creates a memory that this limb is immobile. Ramachandran then proposes mirror therapy 
as a way to “trick [the] eyes into actually seeing a phantom,” (Ramachandran & 
Blakeslee, 1998, p. 46). While Ramachandran mostly abandons the talk of the impact of 
the visual system and returns to the theory of remapping and maladaptive plasticity, I 
believe he may be missing a key component to phantom limb pain.  
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While the theories present for phantom limb pain presented in Chapter 2 are 
backed by support, none of them tell the whole story. Furthermore, they do not fully 
explain why mirror therapy serves as an effective treatment (Young Kim & Young Kim, 
2012). In examining the relief that mirror therapy provides, it does induce changes in the 
somatosensory cortex after four weeks of treatment (Foell et al., 2014). As such, when 
mirror therapy is applied there is a reduction between the asymmetry of the two 
hemispheres. This change supports the theory of central nervous system maladaptive 
plasticity because these changes correlate with phantom limb pain reduction. It does not, 
however, explain the instantaneous relief that some patients receive from mirror therapy 
after one session. Ramachandran describes that the “digging sensation” in one individual 
was eliminated during his first time using the mirror (Ramachandran & Blakeslee, 1998, 
p. 53). Additionally, this same relief in phantom limb pain is seen after five sessions or 
one week of treatment (Chan et al., 2007; Finn et al., 2017). For this reason, the visual 
system’s impact and the conflicting signals the brain is receiving while experiencing 
phantom limb should be expanded upon.  
One such example can be found in the theories behind motion sickness. One 
proposed explanation for motion sickness is called sensory conflict theory. This theory 
proposes that a mismatch is occurring between the visual and vestibular sensations in 
regards to the experience of motion (Kohl, 1983). For example, when an individual is 
reading a book in a car. Their eyes are not sensing movement, but their vestibular system 
is sensing the forward movement of the car. Further investigations of motion sickness 
have supported the role of both systems in the disorder (Ishak, Bubka, & Bonato, 2018; 
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Warwick-Evans, Symons, Fitch, & Burrows, 1998). Due to this mismatch, the individual 
experiences nausea, lethargy, and other symptoms of motion sickness.  
I propose a theory that phantom limb pain may have a similar sensory conflict 
with slightly different systems. While the conflict is still due to a visual system mismatch, 
the mismatch occurs with somatosensory information. The brain does not “see” an arm, 
like Ramachandran discusses, but is still receiving somatosensory input. This 
somatosensory input could be in the form maladaptive plasticity in the central nervous 
system or input from severed peripheral nervous system fibers. One way to investigate 
this hypothesis would be to explore whether there is a reduced frequency, or decreased 
intensity, of phantom limb pain in patients that are blind.  While this may seem like a 
small portion of individuals, blindness and amputations are both complications of 
diabetes and perhaps likely of various forms of war trauma such as with IED explosions. 
This component of phantom limb pain does not discount the other theories developed; 
instead, it adds to the discussion of other confounding factors that could influence pain. 
While developing an experiment is outside the scope of this thesis, these factors warrant 
further research.  
Expanding Outward 
 As I hope this thesis has demonstrated, phantom limb pain is a difficult disorder 
to understand and treat. This difficulty is not just felt by those attempting to research and 
treat the disorder, but by those who experience it. These individuals are who this thesis 
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intends to benefit. At this time, I would like to demonstrate the difficulty that phantom 
limb pain brings to individuals through some quotations.  
 In an article by Nortvedt and Engelsrud (2014), the authors record the words and 
capture pain felt by individuals who have lost a limb. One man who lost his arm to a 
motorcycle accident describes his excruciating phantom limb pain as such: 
It’s as if the skin of my arm has been ripped off; salt is being poured on it and 
then it’s thrust into fire. I also sometimes feel as if the fingers on my amputated 
hand are moving uncontrollably, which is both extremely painful and 
embarrassing (Nortvedt & Engelsrud, 2014, p. 602).  
It is hard for any of us to imagine dealing with that kind of pain on a day-to-day basis. 
While this is just one description, it provides an example of the intensity of pain that 
these individuals feel while experiencing phantom limb pain. A type of pain that no scale 
nor physician could begin to understand.  
In the same article, a man addresses his depression that results from phantom limb pain:  
It’s constant as if I have a big, strange object growing out on my head that I can’t 
get rid of. It’s always there and it drives me crazy. It does something terrible to 
me. I can’t concentrate on anything but the pain. If I read a book I can’t 
concentrate on the text and I don’t remember what I’ve read. I can’t go on living 
like this (Nortvedt & Engelsrud, 2014, p. 604). 
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This quote is striking in that it really puts into context how the pain can affect these 
individuals’ lives. An everyday activity, such as reading, can be impaired by phantom 
limb pain. This debilitation, among other factors, leads to depression in these individuals 
(Ephraim, Wegener, MacKenzie, Dillingham, & Pezzin, 2005). This is why examining 
the pain, and looking for the best way to treat it, is so important for these individuals. 
Moreover, the ideas presented in these quotations expand further than just 
phantom limb pain, but to others who experience other debilitating chronic pain 
disorders. Fibromyalgia, complex regional pain syndrome, migraines, dystonia, and 
restless leg syndrome are just a sampling of disorders, similar to phantom limb pain, 
where the cause is unknown and the treatment is complex and riddled with an array of 
pain killers (Buse et al., 2012; Garcia-Borreguero, Cano-Pumarega, & Marulanda, 2018; 
Mackey & Feinberg, 2007; Painter & Crofford, 2013; Srinivasan, Lim, & Thirugnanam, 
2007). Similar to phantom limb pain, the chronic pain in these disorders can become 
debilitating to the individual’s life.  
Because of this, I hope that this thesis brought forth the idea that more research 
should be done into both the mechanisms and treatments of phantom limb pain and 
related disorders. While it is important to look at and examine further treatments of these 
disorders, I believe that more focus needs to be put on the mechanisms of phantom limb 
pain and related disorders. In doing so, the similarities and differences between chronic 
pain disorders can be discovered. From there, more individualized treatment plans for 
these disorders can be formalized. Because, as seen with the case of phantom limb pain, 
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treatments such as opioids and NSAIDs that work well in relieving many types of pain, 
do not work well when it comes to this disorder. 
I also hope that my thesis brings forth a framework for treatment that can be 
utilized by clinicians when treating phantom limb pain, and other disorders where there is 
limited research on the mechanisms and treatment of the disorder. This thesis began as an 
exploration of the interaction between phantom limb pain and mirror therapy and ended 
with me discovering that I believe it truly should be the first place that treatment should 
start. Through this thesis, I found that physicians often prescribe medications with 
multiple side effects as a way to help alleviate the pain, even though there is little 
research to support them. This is true despite the fact that minimally invasive, low-cost 
treatments, like mirror therapy, are available that have similar degrees of support as the 
medications.  
This thesis has illuminated for me the complexities that arise when examining 
how to treat a patient. While I understand it has only scratched the surface of these 
difficulties, it has shown me how to begin to weigh the pros and cons of various 
treatments when limited information is available. As a future physical therapist, I hope to 
become an advocate for patients with disorders, such as phantom limb pain, that are not 
well understood. As such, I hope to endorse and advance the noninvasive treatment 
options that my future occupation has to offer.  
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